NM_207361.6:c.7398A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_207361.6(FREM2):​c.7398A>G​(p.Thr2466Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.342 in 1,613,642 control chromosomes in the GnomAD database, including 98,682 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 12582 hom., cov: 31)
Exomes 𝑓: 0.34 ( 86100 hom. )

Consequence

FREM2
NM_207361.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -6.37

Publications

22 publications found
Variant links:
Genes affected
FREM2 (HGNC:25396): (FRAS1 related extracellular matrix 2) This gene encodes an integral membrane protein containing numerous CSPG (chondroitin sulfate proteoglycan element) repeats and Calx-beta domains. The encoded protein localizes to the basement membrane, forming a ternary complex that plays a role in epidermal-dermal interactions. This protein is important for the integrity of skin and renal epithelia. Mutations in this gene are associated with Fraser syndrome. [provided by RefSeq, Apr 2014]
FREM2 Gene-Disease associations (from GenCC):
  • Fraser syndrome 2
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • Fraser syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fraser syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-38859469-A-G is Benign according to our data. Variant chr13-38859469-A-G is described in ClinVar as Benign. ClinVar VariationId is 263301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.546 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_207361.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FREM2
NM_207361.6
MANE Select
c.7398A>Gp.Thr2466Thr
synonymous
Exon 14 of 24NP_997244.4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FREM2
ENST00000280481.9
TSL:1 MANE Select
c.7398A>Gp.Thr2466Thr
synonymous
Exon 14 of 24ENSP00000280481.7
ENSG00000294617
ENST00000724728.1
n.134+2433T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.391
AC:
59255
AN:
151738
Hom.:
12538
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.552
Gnomad AMI
AF:
0.312
Gnomad AMR
AF:
0.386
Gnomad ASJ
AF:
0.409
Gnomad EAS
AF:
0.384
Gnomad SAS
AF:
0.447
Gnomad FIN
AF:
0.248
Gnomad MID
AF:
0.405
Gnomad NFE
AF:
0.313
Gnomad OTH
AF:
0.364
GnomAD2 exomes
AF:
0.373
AC:
93785
AN:
251218
AF XY:
0.368
show subpopulations
Gnomad AFR exome
AF:
0.560
Gnomad AMR exome
AF:
0.473
Gnomad ASJ exome
AF:
0.410
Gnomad EAS exome
AF:
0.383
Gnomad FIN exome
AF:
0.258
Gnomad NFE exome
AF:
0.313
Gnomad OTH exome
AF:
0.348
GnomAD4 exome
AF:
0.337
AC:
493132
AN:
1461786
Hom.:
86100
Cov.:
43
AF XY:
0.340
AC XY:
246915
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.559
AC:
18727
AN:
33476
American (AMR)
AF:
0.469
AC:
20963
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.403
AC:
10531
AN:
26136
East Asian (EAS)
AF:
0.386
AC:
15306
AN:
39686
South Asian (SAS)
AF:
0.447
AC:
38574
AN:
86258
European-Finnish (FIN)
AF:
0.259
AC:
13843
AN:
53420
Middle Eastern (MID)
AF:
0.404
AC:
2332
AN:
5766
European-Non Finnish (NFE)
AF:
0.316
AC:
351663
AN:
1111928
Other (OTH)
AF:
0.351
AC:
21193
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
19720
39441
59161
78882
98602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11808
23616
35424
47232
59040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.391
AC:
59353
AN:
151856
Hom.:
12582
Cov.:
31
AF XY:
0.389
AC XY:
28879
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.552
AC:
22846
AN:
41378
American (AMR)
AF:
0.387
AC:
5912
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.409
AC:
1417
AN:
3468
East Asian (EAS)
AF:
0.385
AC:
1973
AN:
5128
South Asian (SAS)
AF:
0.450
AC:
2163
AN:
4812
European-Finnish (FIN)
AF:
0.248
AC:
2616
AN:
10566
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.313
AC:
21272
AN:
67928
Other (OTH)
AF:
0.359
AC:
755
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1722
3444
5166
6888
8610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.342
Hom.:
38077
Bravo
AF:
0.412
Asia WGS
AF:
0.412
AC:
1438
AN:
3478
EpiCase
AF:
0.319
EpiControl
AF:
0.317

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fraser syndrome 2 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Isolated cryptophthalmia Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.090
DANN
Benign
0.47
PhyloP100
-6.4
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9532292; hg19: chr13-39433606; COSMIC: COSV54828922; API